RTO vs. TRI: Which Stock Is the Better Value Option? — Neutral

RTO  TRI   Zacks Investment Research — November 10, 2025

Investors interested in stocks from the Business - Services sector have probably already heard of Rentokil Initial PLC (RTO) and Thomson Reuters (TRI). But which of these two stocks offers value investors a better bang for their buck right now?

image for news RTO vs. TRI: Which Stock Is the Better Value Option?

SOLV or DHR: Which Is the Better Value Stock Right Now? — Positive

DHR  SOLV   Zacks Investment Research — November 10, 2025

Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

image for news SOLV or DHR: Which Is the Better Value Stock Right Now?

HDB or CMWAY: Which Is the Better Value Stock Right Now? — Positive

CMWAY  HDB   Zacks Investment Research — November 10, 2025

Investors interested in Banks - Foreign stocks are likely familiar with HDFC Bank (HDB) and Commonwealth Bank of Australia Sponsored ADR (CMWAY). But which of these two companies is the best option for those looking for undervalued stocks?

image for news HDB or CMWAY: Which Is the Better Value Stock Right Now?

Tesla's best-selling Model Y's program manager, Emmanuel Lamacchia, announced his departure on Sunday after nearly eight years, marking another high-profile exit from Elon Musk's electric vehicle company.

image for news Tesla's Model Y program manager announces exit alongside Cybertruck lead

FOX vs. NFLX: Which Stock Is the Better Value Option? — Positive

FOX  NFLX   Zacks Investment Research — November 10, 2025

Investors interested in Broadcast Radio and Television stocks are likely familiar with Fox Corporation (FOX) and Netflix (NFLX). But which of these two stocks is more attractive to value investors?

image for news FOX vs. NFLX: Which Stock Is the Better Value Option?

JBTM vs. SYM: Which Stock Is the Better Value Option? — Positive

JBTM  SYM   Zacks Investment Research — November 10, 2025

Investors with an interest in Technology Services stocks have likely encountered both JBT Marel (JBTM) and Symbotic Inc. (SYM). But which of these two companies is the best option for those looking for undervalued stocks?

image for news JBTM vs. SYM: Which Stock Is the Better Value Option?

CIB vs. FSS: Which Stock Is the Better Value Option? — Positive

CIB  FSS   Zacks Investment Research — November 10, 2025

Investors looking for stocks in the Diversified Operations sector might want to consider either Grupo Cibest (CIB) or Federal Signal (FSS). But which of these two companies is the best option for those looking for undervalued stocks?

image for news CIB vs. FSS: Which Stock Is the Better Value Option?

Air Products and Chemicals (APD) Could Be a Great Choice — Positive

APD   Zacks Investment Research — November 10, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?

image for news Air Products and Chemicals (APD) Could Be a Great Choice

Why Kroger (KR) is a Great Dividend Stock Right Now — Positive

KR   Zacks Investment Research — November 10, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Kroger (KR) have what it takes?

image for news Why Kroger (KR) is a Great Dividend Stock Right Now

Meta's Plunge Looks Tempting, But It's No Opportunity (Downgrade) — Negative

META   Seeking Alpha — November 10, 2025

Meta Platforms, Inc.'s 20% stock plunge reflects a rational market re-pricing rather than an emotional selloff. Despite strong Q3 growth, Meta's topline expansion is clearly decelerating due to its already saturated user base. Future growth depends heavily on monetization per user, which faces natural limits and sustainability concerns.

image for news Meta's Plunge Looks Tempting, But It's No Opportunity (Downgrade)

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRX

Warren Buffett shares his thoughts on his career and Berkshire's future in a letter.

image for news Berkshire's Buffett to Keep Class A Stock Until Investors Get Comfort With Successor

Wall Street is Pounding the Table Over NVDA, RUN, LLY — Neutral

LLY  NVDA  RUN   24/7 Wall Street — November 10, 2025

In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.

image for news Wall Street is Pounding the Table Over NVDA, RUN, LLY

I Was Wrong About Cavco Industries — Positive

CVCO   Seeking Alpha — November 10, 2025

Cavco Industries is upgraded to a soft "Buy" due to its resilience and growth despite broader housing market weakness. CVCO's niche in factory-built homes, recent acquisition of American Homestar, and strong backlog support continued expansion. The company boasts a fortress balance sheet with no debt and significant cash reserves, enhancing its financial stability.

image for news I Was Wrong About Cavco Industries

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside — Positive

QURE   Seeking Alpha — November 10, 2025

UniQure stock is rated a Buy with a $66 price target, offering upside after recent FDA pushback on AMT-130 Huntington's therapy trial design. AMT-130 is the first disease-modifying therapy for Huntington's, showing 75% slowing of disease progression and significant functional benefit in Phase 1/2 data. Modeling suggests a 78% probability of eventual approval (accelerated or post-Phase 3), with near-term catalysts including FDA meeting minutes and EMA discussions.

image for news From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

Papa John's stock higher on go-private report — Positive

PZZA   Proactive Investors — November 10, 2025

Papa John's International Inc (NASDAQ:PZZA) shares gained 5% to $43.05 on Monday following a report that the pizza maker is in advanced discussions with TriArtisan Capital to be taken private at $65 per share, according to ABC Money UK, which cited people familiar with the talks. The potential acquisition price would value Papa John's at $2.7 billion.

image for news Papa John's stock higher on go-private report

An Earnings Win With a Stock Slump: What's Happening With D-Wave? — Neutral

QBTS   MarketBeat — November 10, 2025

One of the most-hyped earnings reports of the quantum industry this season ended not with a rally, but a retreat. Shares of D-Wave Quantum Inc. NYSE: QBTS fell by nearly 22% in the first full week of trading in November 2025, closing the week under $30 per share.

image for news An Earnings Win With a Stock Slump: What's Happening With D-Wave?

Bakkt Holdings, Inc. (BKKT) Q3 2025 Earnings Call Transcript — Neutral

BKKT   Seeking Alpha — November 10, 2025

Bakkt Holdings, Inc. ( BKKT ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Cody Fletcher Akshay Naheta - CEO & Director Karen Alexander - CFO & Principal Financial Officer Conference Call Participants Chris Brendler Mark Palmer - The Benchmark Company, LLC, Research Division Justin Pan Presentation Operator Greetings, and welcome to the Bakkt's Third Quarter 2025 Earnings Conference Call. [Operator Instructions].

image for news Bakkt Holdings, Inc. (BKKT) Q3 2025 Earnings Call Transcript

Lithium Argentina AG (LAR:CA) Q3 2025 Earnings Call Transcript — Neutral

LAR   Seeking Alpha — November 10, 2025

Lithium Argentina AG ( LAR:CA ) Q3 2025 Earnings Call November 10, 2025 8:00 AM EST Company Participants Kelly O'Brien - VP of Investor Relations & ESG Sam Pigott - CEO, President & Director Xiaoshen Wang - President & Vice Chairman Jason Luo Carlos Galli - Chief Operating Officer Conference Call Participants Joel Jackson - BMO Capital Markets Equity Research Katie Lachapelle - Canaccord Genuity Corp., Research Division Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Corinne Blanchard - Deutsche Bank AG, Research Division David Deckelbaum - TD Cowen, Research Division Mohamed Sidibe - National Bank Financial, Inc., …

image for news Lithium Argentina AG (LAR:CA) Q3 2025 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. ( ALNY ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Jeffrey Poulton - CFO & Executive VP John Vest - Senior Vice President of Clinical Research Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division All right. Good day, everybody.

image for news Alnylam Pharmaceuticals, Inc. (ALNY) Presents at UBS Global Healthcare Conference 2025 Transcript